204 related articles for article (PubMed ID: 12719746)
1. Cognitive dysfunction following adjuvant chemotherapy for breast cancer: two case studies.
Paraska K; Bender CM
Oncol Nurs Forum; 2003; 30(3):473-8. PubMed ID: 12719746
[TBL] [Abstract][Full Text] [Related]
2. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
[TBL] [Abstract][Full Text] [Related]
3. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.
Tchen N; Juffs HG; Downie FP; Yi QL; Hu H; Chemerynsky I; Clemons M; Crump M; Goss PE; Warr D; Tweedale ME; Tannock IF
J Clin Oncol; 2003 Nov; 21(22):4175-83. PubMed ID: 14615445
[TBL] [Abstract][Full Text] [Related]
4. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.
Falleti MG; Sanfilippo A; Maruff P; Weih L; Phillips KA
Brain Cogn; 2005 Oct; 59(1):60-70. PubMed ID: 15975700
[TBL] [Abstract][Full Text] [Related]
5. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
[TBL] [Abstract][Full Text] [Related]
6. 'Chemobrain' in breast carcinoma?: a prologue.
Wefel JS; Lenzi R; Theriault R; Buzdar AU; Cruickshank S; Meyers CA
Cancer; 2004 Aug; 101(3):466-75. PubMed ID: 15274059
[TBL] [Abstract][Full Text] [Related]
7. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
Fan HG; Houédé-Tchen N; Yi QL; Chemerynsky I; Downie FP; Sabate K; Tannock IF
J Clin Oncol; 2005 Nov; 23(31):8025-32. PubMed ID: 16258100
[TBL] [Abstract][Full Text] [Related]
8. Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment.
Collins B; Mackenzie J; Stewart A; Bielajew C; Verma S
Psychooncology; 2009 Feb; 18(2):134-43. PubMed ID: 18551510
[TBL] [Abstract][Full Text] [Related]
9. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.
Downie FP; Mar Fan HG; Houédé-Tchen N; Yi Q; Tannock IF
Psychooncology; 2006 Oct; 15(10):921-30. PubMed ID: 16477674
[TBL] [Abstract][Full Text] [Related]
10. Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study.
Biglia N; Bounous VE; Malabaila A; Palmisano D; Torta DM; D'Alonzo M; Sismondi P; Torta R
Eur J Cancer Care (Engl); 2012 Jul; 21(4):485-92. PubMed ID: 22211832
[TBL] [Abstract][Full Text] [Related]
11. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer.
Wefel JS; Saleeba AK; Buzdar AU; Meyers CA
Cancer; 2010 Jul; 116(14):3348-56. PubMed ID: 20564075
[TBL] [Abstract][Full Text] [Related]
12. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
[TBL] [Abstract][Full Text] [Related]
13. The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients.
Schagen SB; Das E; van Dam FS
Psychooncology; 2009 Jun; 18(6):674-8. PubMed ID: 19021129
[TBL] [Abstract][Full Text] [Related]
14. The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study.
Stewart A; Collins B; Mackenzie J; Tomiak E; Verma S; Bielajew C
Psychooncology; 2008 Feb; 17(2):122-30. PubMed ID: 17518411
[TBL] [Abstract][Full Text] [Related]
15. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.
Hurria A; Rosen C; Hudis C; Zuckerman E; Panageas KS; Lachs MS; Witmer M; van Gorp WG; Fornier M; D'Andrea G; Moasser M; Dang C; Van Poznak C; Hurria A; Holland J
J Am Geriatr Soc; 2006 Jun; 54(6):925-31. PubMed ID: 16776787
[TBL] [Abstract][Full Text] [Related]
16. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients.
Schagen SB; Muller MJ; Boogerd W; Mellenbergh GJ; van Dam FS
J Natl Cancer Inst; 2006 Dec; 98(23):1742-5. PubMed ID: 17148777
[TBL] [Abstract][Full Text] [Related]
17. The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer.
Fan HG; Park A; Xu W; Yi QL; Braganza S; Chang J; Couture F; Tannock IF
Psychooncology; 2009 Feb; 18(2):156-61. PubMed ID: 18561284
[TBL] [Abstract][Full Text] [Related]
18. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study.
Hermelink K; Henschel V; Untch M; Bauerfeind I; Lux MP; Munzel K
Cancer; 2008 Nov; 113(9):2431-9. PubMed ID: 18823033
[TBL] [Abstract][Full Text] [Related]
19. Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results.
Weis J; Poppelreuter M; Bartsch HH
Psychooncology; 2009 Jul; 18(7):775-82. PubMed ID: 19061196
[TBL] [Abstract][Full Text] [Related]
20. No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy.
Mehlsen M; Pedersen AD; Jensen AB; Zachariae R
Psychooncology; 2009 Mar; 18(3):248-57. PubMed ID: 18756583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
